Basic and Translational Research: 1.7. Systemic lupus erythematosus, Sjögren's, systemic vasculitis and antiphospholipid syndrome - pathogenesis and animal modelsBACKGROUND: Dendritic cells (DCs), professional antigen presenting cells which link the innate and adaptive immune systems, play an important role in inducing immunity and tolerance. Systemic lupus erythematosus (SLE), an autoimmune disease with loss of tolerance to self antigens, is suggested to have apoptotic cells as the source of antigens. Foxp3, a transcription factor, is suggested to be …link_to_OA_fulltextThe 14th Congress of Asia Pacific League of Associations for Rheumatology, Hong Kong, China, 11-15 July 2010. In International Journal of Rheumatic Diseases, 2010, v. 13 su...
Systemic lupus erythematosus (SLE) persists as a chronic inflammatory autoimmune disease and is char...
Innate immunity is the first-line host defence against pathogens and damaged host cells, and the maj...
Clinical Research: 2.6 Systemic lupus erythematosus, Sjögren’s and antiphospholipid syndrome – thera...
Basic and Translational Research: 1.7. Systemic lupus erythematosus, Sjögren's, systemic vasculitis ...
Background Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) as autoimmune diseases a...
Basic and Translational Research: 1.7. Systemic lupus erythematosus, Sjögren's, systemic vasculitis ...
International audienceSystemic lupus erythematosus (SLE) is a heterogeneous disease in which excessi...
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of immun...
Systemic lupus erythematosus (SLE) is a heavily female-biased, chronic and multifactorial autoimmune...
T regulatory (Treg) cells expressing the transcription factor FoxP3 play a key role in protection ag...
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of immun...
Maintenance of lymphoid homeostasis in a number of immunological and inflammatory contexts is served...
T regulator lymphocytes (Tregs) play a key role in the maintenance of immune tolerance and in the d...
Abstract The discovery of the transcription factor Forkhead box-p3 (Foxp3) has shed fundamental ins...
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of immun...
Systemic lupus erythematosus (SLE) persists as a chronic inflammatory autoimmune disease and is char...
Innate immunity is the first-line host defence against pathogens and damaged host cells, and the maj...
Clinical Research: 2.6 Systemic lupus erythematosus, Sjögren’s and antiphospholipid syndrome – thera...
Basic and Translational Research: 1.7. Systemic lupus erythematosus, Sjögren's, systemic vasculitis ...
Background Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) as autoimmune diseases a...
Basic and Translational Research: 1.7. Systemic lupus erythematosus, Sjögren's, systemic vasculitis ...
International audienceSystemic lupus erythematosus (SLE) is a heterogeneous disease in which excessi...
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of immun...
Systemic lupus erythematosus (SLE) is a heavily female-biased, chronic and multifactorial autoimmune...
T regulatory (Treg) cells expressing the transcription factor FoxP3 play a key role in protection ag...
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of immun...
Maintenance of lymphoid homeostasis in a number of immunological and inflammatory contexts is served...
T regulator lymphocytes (Tregs) play a key role in the maintenance of immune tolerance and in the d...
Abstract The discovery of the transcription factor Forkhead box-p3 (Foxp3) has shed fundamental ins...
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of immun...
Systemic lupus erythematosus (SLE) persists as a chronic inflammatory autoimmune disease and is char...
Innate immunity is the first-line host defence against pathogens and damaged host cells, and the maj...
Clinical Research: 2.6 Systemic lupus erythematosus, Sjögren’s and antiphospholipid syndrome – thera...